Enwave Corporation Stock
Your prediction
Enwave Corporation Stock
Heavy losses for Enwave Corporation today as the stock fell by -€0.005 (-3.650%).
Pros and Cons of Enwave Corporation in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Enwave Corporation vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enwave Corporation | -3.650% | -6.383% | -14.839% | -44.068% | -44.068% | -46.774% | -81.461% |
| Aurinia Pharmaceuticals Inc. | 0.870% | 4.901% | 7.055% | 102.371% | 6.459% | 62.955% | 31.019% |
| Spectral Medical Inc | -1.200% | -1.198% | -3.509% | 52.778% | 3.774% | 382.456% | 178.716% |
| Xenon Pharmaceuticals Inc. | - | 2.655% | 0.433% | 66.906% | 22.105% | 24.064% | - |
News
EnWave Reports 2026 First Quarter Consolidated Interim Financial Results
Vancouver, B.C., February 20th, 2026. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the first
EnWave Signs Royalty-Bearing License with Bowen Gumlu Grower’s Association of Australia
Vancouver, B.C., February 2nd, 2026, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today announced that the Company has signed a royalty-bearing commercial license